Video

How Can Access to PCSK9 Inhibitors be Improved?

Author(s):

Lauren Santye, Assistant Editor

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist for UMass Medical School Clinical Pharmacy Services, discusses potential solutions for access to cholesterol lowering drugs to improve.

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist for UMass Medical School Clinical Pharmacy Services, discusses potential solutions for access to cholesterol lowering drugs to improve.

Related Videos
Related Content
Wildfire, Pharmacy, Preparedness | Image Credit: JAH | stock.adobe.com
January 10th 2025

As Wildfires Spread Across California, Pharmacists' Role in the Crisis Proves Essential

Ashley Gallagher, Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Primary biliary cholangitis written on post-it note -- Image credit: syahrir | stock.adobe.com
January 10th 2025

FDA Grants Orphan Drug Designation to CNP-104 for Primary Biliary Cholangitis

Gillian McGovern, Associate Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

FDA headquarters at White Oak Campus in Silver Spring, Maryland, USA - January 13, 2020. The United States Food and Drug Administration (FDA) is a federal agency
January 9th 2025

FDA Grants Breakthrough Therapy Designation to Tividenofusp Alfa for Treatment of Hunter Syndrome

Luke Halpern, Assistant Editor
Microscopic image of an adrenal cortical adenoma, a benign tumor of the adrenal gland, which may produce hormones cortisol or aldosterone and lead to Cushing's syndrome or primary hyperaldosteronism.
January 6th 2025

Relacorilant NDA Submitted to FDA for Treatment of Endogenous Hypercortisolism

Luke Halpern, Assistant Editor